Dupont Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8,629	Closed	-$161K	–	1567
2022 Q2	$161K	Buy	8,629 +2,297	+36%	+$42.9K	0.01%	1037
2022 Q1	$139K	Sell	6,332 -561	-8%	-$12.3K	0.01%	1195
2021 Q4	$196K	Buy	+6,893	New	+$196K	0.01%	1117